Michael Kulke
10Patents
1h-index
13Co-inventors
47Inventor score
Filing activity: Jul 14, 2006 → Feb 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7378401B2 | Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases | Human Necessities | 1 | Active |
| US11420971B2 | Method for synthesizing amanitins | Emerging Cross-Sectional Technologies | 1 | Active |
| US11446388B2 | Amanitin antibody conjugates | Chemistry; Metallurgy | 0 | Active |
| US11590238B2 | Amanitin conjugates | Chemistry; Metallurgy | 0 | Active |
| US10961277B2 | Method for synthesizing amanitins | Emerging Cross-Sectional Technologies | 0 | Active |
| US12201693B2 | Amanitin conjugates | Chemistry; Metallurgy | 0 | Active |
| US11702451B2 | Method for synthesizing amanitins | Emerging Cross-Sectional Technologies | 0 | Active |
| US11583569B2 | PSMA-targeting amanitin conjugates | Human Necessities | 0 | Active |
| US11926631B2 | Method of treating cancer using amanitin derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12403201B2 | B-lymphocyte specific amatoxin antibody conjugates | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.